Company Overview and News

 
S&P/ASX 200 regains losses to finish flat, China futures take a dive

2018-02-20 proactiveinvestors.com.au
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) has rallied back from its morning low to finish flat at 5,941.
Upvote Downvote

 
S&P/ASX 200 rallies into the afternoon session, China futures dive

2018-02-20 proactiveinvestors.com.au
Interestingly, although China share markets are closed, their futures took a jolt at midday AEST time.
Upvote Downvote

 
Resources spending boosts Monadelphous H1

2018-02-20 businessnews.com.au
Engineering services firm Monadelphous Group has lifted half-year profit by nearly a third as it rides the rebound in activity in the resources sector.
Upvote Downvote

 
S&P/ASX 200 rallies back but still down 0.3% after midday

2018-02-20 proactiveinvestors.com.au
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) has rallied off its lows this morning but still remains in negative territory.
Upvote Downvote

 
S&P/ASX 200 opened down 0.4% as it gives back yesterday's gains

2018-02-20 proactiveinvestors.com.au
S&P/ASX 200 was set to open slightly lower earlier today with the ASX 200 futures down to 5,866.5, roughly 35 points lower than yesterday’s XJO close.
Upvote Downvote

 
S&P/ASX 200 set to open slightly lower according to futures

2018-02-19 proactiveinvestors.com.au
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) is set to open slightly lower today with the ASX200 futures down to 5,866.5, roughly 35 points lower than yesterday’s XJO close.
Upvote Downvote

 
AnaeCo into administration

2017-12-18 businessnews.com.au
ASX-listed AnaeCo has gone into administration after Monadelphous Group terminated an $11.5 million contract with the waste technology company and a Chinese enterprise.
Upvote Downvote

 
Macmahon appoints new CFO

2017-12-18 businessnews.com.au
Mining contractor Macmahon Holdings has announced that former director Giles Everist has been appointed as the company’s chief financial officer.
Upvote Downvote

 
Monadelphous tips 30% growth

2017-11-21 businessnews.com.au
Engineering and construction contractor Monadelphous Group has painted a positive outlook after tough trading conditions in recent years, with the company tipping strong revenue growth in the current financial year.
Upvote Downvote

 
Monadelphous wins $220m of resources contracts

2017-09-26 australianmining.com.au
The new maintenance work includes a two-year contract to supply fixed maintenance services for Rio Tinto at its Pilbara operations. This is a continuation of existing work.
Upvote Downvote

 
Monadelphous wins $55m in new work

2017-07-19 businessnews.com.au
Monadelphous Group has announced the award of three contracts in the mining, energy and renewables sectors, to the tune of $55 million.
Upvote Downvote

 
Monadelphous pours cold water over acquisition talks

2017-06-29 businessnews.com.au
Monadelphous Group has hosed down speculation that it is eyeing a $300 million acquisition of a civil engineering company, but the rumours have fuelled investor interest.
Upvote Downvote

 
Monadelphous wins more Ichthys work

2017-06-26 businessnews.com.au
Engineering firm Monadelphous Group has announced the award of two new contracts to the tune of $170 million, one of which is for further work on the Ichthys LNG project in Darwin.
Upvote Downvote

 
Monadelphous wins $600m Woodside contract

2017-06-21 businessnews.com.au
Monadelphous Group has won a five-year contract to provide its services to a number of Woodside Petroleum’s operations in the North West.
Upvote Downvote

 
Monadelphous wins $125m in new work

2017-06-13 businessnews.com.au
Monadelphous Group has won a contract to complete cryogenic tanks at the Ichthys LNG project in Darwin – the same job that Laing O’Rourke walked away from in March.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...